Higher capecitabine AUC in elderly patients with advanced colorectal cancer (SWOGS0030)

被引：0
|
作者：
S G Louie
B Ely
H-J Lenz
K S Albain
C Gotay
D Coleman
D Raghavan
A F Shields
P J Gold
C D Blanke
机构：
[1] University of Southern California,Department of Pharmacy
[2] Norris Comprehensive Cancer Center,Department of Oncology
[3] Loyola University Chicago/Cardinal Bernardin Cancer Center,undefined
[4] University of British Columbia,undefined
[5] Cancer Research Center of Hawaii,undefined
[6] Carolinas Medical Center/Levine Cancer Institute,undefined
[7] Karmanos Cancer Institute/Wayne State University,undefined
[8] Swedish Cancer Institute,undefined
[9] Knight Cancer Institute and SWOG,undefined
来源：
British Journal of Cancer | 2013年 / 109卷
关键词：
elderly; pharmacokinetics; colorectal cancer; capecitabine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1744 / 1749
页数：5
相关论文
共 50 条
  • [1] Higher capecitabine AUC in elderly patients with advanced colorectal cancer (SWOGS0030)
    Louie, S. G.
    Ely, B.
    Lenz, H-J
    Albain, K. S.
    Gotay, C.
    Coleman, D.
    Raghavan, D.
    Shields, A. F.
    Gold, P. J.
    Blanke, C. D.
    BRITISH JOURNAL OF CANCER, 2013, 109 (07) : 1744 - 1749
  • [2] Adjuvant Capecitabine and Oxaliplatin for Elderly Patients with Colorectal Cancer
    Okamoto, Kazuaki
    Nozawa, Hiroaki
    Emoto, Shigenobu
    Murono, Koji
    Sasaki, Kazuhito
    Ishihara, Soichiro
    ONCOLOGY, 2022, 100 (11) : 576 - 582
  • [3] Outcomes in elderly patients with advanced colorectal cancer treated with capecitabine: A population-based analysis
    Ho, Cheryl
    Ng, Kathy
    O'Reilly, Susan
    Gill, Sharlene
    CLINICAL COLORECTAL CANCER, 2005, 5 (04) : 279 - 282
  • [4] Irinotecan in colorectal cancer in elderly patients with advanced colorectal cancer
    Sastre, J.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2007, 64 : S22 - S22
  • [5] Phase I/II trial of dose-reduced capecitabine in elderly patients with advanced colorectal cancer
    Vincent, M. D.
    Breadner, D.
    Cripps, M. C.
    Jonker, D. J.
    Klimo, P.
    Biagi, J. J.
    Lam, W.
    O'Connell, A.
    Whiston, F.
    Stitt, L.
    Welch, S. A.
    CURRENT ONCOLOGY, 2017, 24 (04) : E261 - E268
  • [6] WEEKLY OXALIPLATIN AND CAPECITABINE CONTINUOUSLY IN ELDERLY PATIENTS WITH ADVANCED COLORECTAL CANCER (ACRC). A PHASE II STUDY
    Pochettino, Paolo
    Bergnolo, Paola
    Boglione, Antonella
    Dal Canton, Orietta
    Cutin, Simona Chiado
    Garetto, Ferdinando
    Biscardi, Emanuela
    Comandone, Alessandro
    ANNALS OF ONCOLOGY, 2004, 15 : 61 - 61
  • [7] Gemcitabine plus capecitabine in elderly patients with advanced pancreatic cancer
    Vasiliki, Michalaki
    Andreas, Poydorou
    Antonios, Vezakis
    Georgios, Frangulidis
    Theodosios, Theodosopoulos
    Christos, Papadimitriou
    ANNALS OF ONCOLOGY, 2017, 28
  • [8] Capecitabine as third line therapy in patients with advanced colorectal cancer
    Gubanski, M
    Naucler, G
    Almerud, A
    Lideståhl, A
    Lind, PARM
    ACTA ONCOLOGICA, 2005, 44 (03) : 236 - 239
  • [9] Capecitabine and irinotecan with and without bevacizumab for advanced colorectal cancer patients
    Moehler, Markus
    Sprinzl, Martin F.
    Abdelfattah, Murad
    Schimanski, Carl C.
    Adami, Bernd
    Godderz, Werner
    Majer, Klaus
    Flieger, Dimitri
    Teufel, Andreas
    Siebler, Juergen
    Hoehler, Thomas
    Galle, Peter R.
    Kanzler, Stephan
    WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (04) : 449 - 456
  • [10] Capecitabine and irinotecan with and without bevacizumab for advanced colorectal cancer patients
    Markus Moehler
    Martin F Sprinzl
    Murad Abdelfattah
    Carl C Schimanski
    Bernd Adami
    Werner Godderz
    Klaus Majer
    Dimitri Flieger
    Andreas Teufel
    Juergen Siebler
    Thomas Hoehler
    Peter R Galle
    Stephan Kanzler
    World Journal of Gastroenterology, 2009, 15 (04) : 449 - 456
12345